Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amnestic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05446584
What this trial is testing

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Who this might be right for
Mild Cognitive ImpairmentAmnestic Mild Cognitive DisorderAmnestic Mild Cognitive Impairment+2 more
University of Texas Southwestern Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT02957123
What this trial is testing

Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome

Who this might be right for
Organic Brain Syndrome, NonpsychoticNeurocognitive DisordersMental Disorder, Organic+6 more
Russian Academy of Medical Sciences 30
Not applicableStudy completedNCT02574182
What this trial is testing

Study of Motor Representations in Healthy Subjects and Amnestic MCI

Who this might be right for
Mild Cognitive Impairment
University Hospital, Angers 97
Not applicableStudy completedNCT05584241
What this trial is testing

Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure

Who this might be right for
Mild Cognitive ImpairmentAlzheimer DiseaseAmnestic Mild Cognitive Disorder
University of Michigan 102
Testing effectiveness (Phase 2)Study completedNCT01354691
What this trial is testing

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaMemory Loss+1 more
Avraham Pharmaceuticals Ltd 200
Large-scale testing (Phase 3)Ended earlyNCT02783573
What this trial is testing

Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia

Who this might be right for
Alzheimer's Disease
AstraZeneca 1,722
Not applicableStudy completedNCT01962038
What this trial is testing

A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment

Who this might be right for
Amnestic Mild Cognitive Impairment
Palo Alto Veterans Institute for Research 72
Testing effectiveness (Phase 2)Study completedNCT01044758
What this trial is testing

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment (MCI)
Johns Hopkins University 96
Not applicableStudy completedNCT05564715
What this trial is testing

Cognitive Outcomes of Brain Stimulation As a Later-in-Life Treatment

Who this might be right for
Mild Cognitive ImpairmentAmnestic Mild Cognitive Impairment - aMCI
University of Texas Southwestern Medical Center 27
Not applicableUnknownNCT01455207
What this trial is testing

From Uncomplicated Alcoholism to Korsakoff's Syndrome

Who this might be right for
AlcoholismAlcohol Amnestic Disorder
University Hospital, Caen 220
Testing effectiveness (Phase 2)Study completedNCT01928420
What this trial is testing

A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Humanetics Corporation 30
Testing effectiveness (Phase 2)Study completedNCT01276353
What this trial is testing

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

Who this might be right for
Alzheimer's Type Dementia
Eisai Inc. 45
Post-approval studies (Phase 4)Ended earlyNCT00757913
What this trial is testing

N-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac Surgery

Who this might be right for
Delirium, Dementia, Amnestic, Cognitive DisordersPostoperative Cognitive Dysfunction
University Hospital, Basel, Switzerland 400
Not applicableLooking for participantsNCT07449117
What this trial is testing

Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases

Who this might be right for
Mild Cognitive Impairment (MCI) AmnesticLewy Body Disease With Mild Cognitive ImpairmentParkinson's Disease With Mild Cognitive Impairment
Masaryk University 70
Not applicableUnknownNCT01696591
What this trial is testing

The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD

Who this might be right for
Alzheimer DiseaseDementiaBrain Diseases+6 more
Duk Lyul Na 14
Not applicableLooking for participantsNCT07272811
What this trial is testing

Neurocognitive Assessment Platform 4 Alzheimer

Who this might be right for
MCIMCI Conversion to DementiaAMCI - Amnestic Mild Cognitive Impairment+1 more
IRCCS San Raffaele 100
Testing effectiveness (Phase 2)Study completedNCT05515952
What this trial is testing

Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
University of Arizona 25
Not applicableStudy completedNCT02785315
What this trial is testing

Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
National Taiwan University Hospital 40
Not applicableEnded earlyNCT04482036
What this trial is testing

The MObile AssessMENT of Behavioral and Psychological Symptoms of Dementia in Amnestic MCI and AD (MOMENT) Study

Who this might be right for
Alzheimer DiseaseMild Memory DisturbanceMild Cognitive Impairment
Indiana University 20
Early research (Phase 1)Ended earlyNCT01072812
What this trial is testing

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

Who this might be right for
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Annovis Bio Inc. 5
Next Page